← back to search

Matthias Baumann

Innsbruck Medical University · AT
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Neurogenetic and Muscular Disorders Research, and Autoimmune Neurological Disorders and Treatments.
h-index
53
citations
9,816
works
252
NIH funding
primary concept
email

Recent publications

Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia
Brain 2025cited by 20position: middledoi
Characterization of children with early onset pediatric multiple sclerosis
European Journal of Paediatric Neurology 2025cited by 4position: middledoi
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
JAMA Pediatrics 2024cited by 57position: middledoi
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study
The Lancet Regional Health - Europe 2024cited by 25position: middledoi
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth
Journal of Experimental & Clinical Cancer Research 2023cited by 34position: middledoi
Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis
Neurology Neuroimmunology & Neuroinflammation 2023cited by 9position: middledoi
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
Neurology 2022cited by 81position: middledoi
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy
Brain 2022cited by 68position: middledoi
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study
Orphanet Journal of Rare Diseases 2022cited by 40position: middledoi
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects
Journal for ImmunoTherapy of Cancer 2021cited by 75position: middledoi
Biallelic <scp><i>AOPEP</i></scp> Loss‐of‐Function Variants Cause Progressive Dystonia with Prominent Limb Involvement
Movement Disorders 2021cited by 22position: middledoi
Monogenic variants in dystonia: an exome-wide sequencing study
The Lancet Neurology 2020cited by 209position: middledoi
E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
European Journal of Paediatric Neurology 2020cited by 135position: middledoi
E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
European Journal of Paediatric Neurology 2020cited by 59position: firstdoi
High association of MOG-IgG antibodies in children with bilateral optic neuritis
European Journal of Paediatric Neurology 2020cited by 41position: middledoi
Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach
Journal of Medicinal Chemistry 2020cited by 18position: middledoi
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal Cancer
Cancer Research 2019cited by 90position: middledoi
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
Haematologica 2019cited by 90position: middledoi
Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure
Multiple Sclerosis Journal 2019cited by 55position: middledoi
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S
Chemical Science 2019cited by 51position: middledoi
Grasslands and Open Savannas of the Dry Chaco
Elsevier eBooks 2019cited by 23position: middledoi
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
JAMA Neurology 2018cited by 412position: middledoi
Germline De Novo Mutations in ATP1A1 Cause Renal Hypomagnesemia, Refractory Seizures, and Intellectual Disability
The American Journal of Human Genetics 2018cited by 93position: middledoi
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor
Journal of Medicinal Chemistry 2017cited by 55position: middledoi
Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: A guideline by the working group “Clinical Tissue Regeneration” of the German Society of Orthopaedics and Trauma (DGOU)
The Knee 2016cited by 197position: middledoi
C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
Nephrology Dialysis Transplantation 2016cited by 197position: middledoi
Stellenwert der autologen Chondrozytentransplantation (ACT) in der Behandlung von Knorpelschäden des Kniegelenks - Empfehlungen der AG Klinische Geweberegeneration der DGOU
Zeitschrift für Orthopädie und Unfallchirurgie 2013cited by 74position: middledoi
Amorfrutins are potent antidiabetic dietary natural products
Proceedings of the National Academy of Sciences 2012cited by 204position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kevin Rostásy · Witten/Herdecke University6 papers (2018–2023)Frederik Bartels · Charité - Universitätsmedizin Berlin4 papers (2019–2023)Christian Lechner · University of London4 papers (2018–2020)Carsten Finke · Max Delbrück Center4 papers (2019–2023)Ming Lim · Utah Department of Health3 papers (2018–2020)Rinze F. Neuteboom · Erasmus MC3 papers (2018–2020)Yael Hacohen · Queen Mary University of London3 papers (2018–2020)Michael Karenfort · Antea Group (France)3 papers (2019–2023)Kumaran Deiva · Inserm3 papers (2018–2020)Astrid Blaschek · Antea Group (France)3 papers (2019–2023) · 3 papers (2020–2020)Evangeline Wassmer · Aston University3 papers (2018–2020)Diana Beyer · National Center for Tumor Diseases3 papers (2016–2021) · 2 papers (2020–2020)Ronny Wickström · Karolinska University Hospital2 papers (2020–2020)Steffen Leiz · München Klinik2 papers (2020–2023)Markus Breu · University of Vienna2 papers (2020–2020) · 2 papers (2017–2020)Graham Cooper · Humboldt-Universität zu Berlin2 papers (2019–2023)Sebastian Bauer · TU Dortmund University2 papers (2017–2020)